166 related articles for article (PubMed ID: 28763860)
1. [Role of enolase 1 in hepatocellular carcinoma and possible mechanism].
Yan TT; Ma LN; Luo X; Lu ZH; Liu Q; Xu YH; Liu XL; Ding XC
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):429-434. PubMed ID: 28763860
[No Abstract] [Full Text] [Related]
2. Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma.
Zhu X; Yu H; Li B; Quan J; Zeng Z; Li G; Liu J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 30541900
[TBL] [Abstract][Full Text] [Related]
3. Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells.
Chen X; Xu H; Wu N; Liu X; Qiao G; Su S; Tian Y; Yuan R; Li C; Liu X; Lin X
Oncotarget; 2017 May; 8(18):30305-30316. PubMed ID: 28415822
[TBL] [Abstract][Full Text] [Related]
4. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1.
Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X
Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748
[TBL] [Abstract][Full Text] [Related]
5. Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis.
Jiang K; Dong C; Yin Z; Li R; Mao J; Wang C; Zhang J; Gao Z; Liang R; Wang Q; Wang L
Cell Death Dis; 2020 Nov; 11(11):972. PubMed ID: 33184263
[TBL] [Abstract][Full Text] [Related]
6. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
7. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
[TBL] [Abstract][Full Text] [Related]
8. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
9. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
10. [Effect and mechanism of siRNA targeting α-enolase gene combined with paclitaxel on proliferation, invasion and apoptosis of hepatocellular carcinoma cell].
Cui H; Gao QQ; Zhuang H; He T; Wan BS; Wang XQ; Zhang L; Huang T; Han F
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1241-1247. PubMed ID: 34915631
[No Abstract] [Full Text] [Related]
11. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
[TBL] [Abstract][Full Text] [Related]
12. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
13. Silencing of ENO1 inhibits the proliferation, migration and invasion of human breast cancer cells.
Zhang J; Li H; Miao L; Ding J
J BUON; 2020; 25(2):696-701. PubMed ID: 32521855
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of α-enolase affects the biological activity of breast cancer cells by attenuating PI3K/Akt signaling pathway.
Zang HY; Gong LG; Li SY; Hao JG
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):249-257. PubMed ID: 31957838
[TBL] [Abstract][Full Text] [Related]
16. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
17. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
[TBL] [Abstract][Full Text] [Related]
18. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
19. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
20. Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells.
Yuan Y; Yuan HF; Geng Y; Zhao LN; Yun HL; Wang YF; Yang G; Zhang XD
Biochem Biophys Res Commun; 2021 Jun; 560():172-178. PubMed ID: 34000466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
